CNR Institutional Research Information System

SINI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.754
NA - Nord America 1.829
EU - Europa 877
SA - Sud America 472
Continente sconosciuto - Info sul continente non disponibili 143
AF - Africa 45
OC - Oceania 3
Totale 6.123
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.724
SG - Singapore 1.067
CN - Cina 575
IT - Italia 396
BR - Brasile 372
HK - Hong Kong 304
VN - Vietnam 263
BD - Bangladesh 140
FR - Francia 136
JP - Giappone 135
NL - Olanda 105
KR - Corea 81
DE - Germania 58
IN - India 53
CA - Canada 49
GB - Regno Unito 46
FI - Finlandia 25
ID - Indonesia 25
AR - Argentina 23
CO - Colombia 21
MX - Messico 21
EC - Ecuador 19
ZA - Sudafrica 18
IL - Israele 17
VE - Venezuela 15
AT - Austria 14
IE - Irlanda 14
IQ - Iraq 14
PH - Filippine 11
PL - Polonia 10
SA - Arabia Saudita 10
KE - Kenya 9
RU - Federazione Russa 9
TR - Turchia 8
UY - Uruguay 8
CZ - Repubblica Ceca 7
ES - Italia 7
JM - Giamaica 7
PK - Pakistan 7
MA - Marocco 6
PY - Paraguay 6
TH - Thailandia 6
UA - Ucraina 6
CR - Costa Rica 5
HN - Honduras 5
LT - Lituania 5
MY - Malesia 5
CH - Svizzera 4
KZ - Kazakistan 4
NI - Nicaragua 4
PE - Perù 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
AL - Albania 3
BG - Bulgaria 3
DZ - Algeria 3
EE - Estonia 3
HU - Ungheria 3
NO - Norvegia 3
SE - Svezia 3
AM - Armenia 2
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
MM - Myanmar 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
SC - Seychelles 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CU - Cuba 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
ME - Montenegro 1
Totale 5.972
Salva come PNG Salva come JPEG
Città #
Singapore 612
Santa Clara 312
Hong Kong 300
San Jose 237
Hefei 188
Ashburn 122
Tokyo 120
Lauterbourg 112
Beijing 106
Ho Chi Minh City 99
Seoul 78
Los Angeles 72
Hanoi 70
Dallas 57
New York 38
São Paulo 37
Council Bluffs 31
Milan 30
Cavallino 29
Genoa 25
Rome 25
Cagliari 20
Phoenix 18
Naples 16
Buffalo 15
Brooklyn 14
Dublin 14
Helsinki 14
Amsterdam 13
Frankfurt am Main 13
Rio de Janeiro 13
Florence 12
Minamishinagawa 12
Montreal 12
Orem 12
Boardman 11
Guangzhou 11
Houston 11
Johannesburg 10
Nuremberg 10
Porto Alegre 10
Turin 10
Boston 9
Chicago 9
Curitiba 9
Düsseldorf 9
Philadelphia 9
Vienna 9
Denver 8
Jacksonville 8
Las Vegas 8
Manchester 8
Memphis 8
Nairobi 8
Sala Baganza 8
Toronto 8
Atlanta 7
Bengaluru 7
Charlotte 7
Chennai 7
Hải Dương 7
Jakarta 7
Montevideo 7
Mumbai 7
Salvador 7
San Francisco 7
St Louis 7
The Bronx 7
Turku 7
Belo Horizonte 6
Bogotá 6
London 6
Miami 6
Munich 6
Riyadh 6
Seattle 6
Bari 5
Brasília 5
Brescia 5
Bắc Giang 5
Chandigarh 5
Da Nang 5
Dhaka 5
Duque de Caxias 5
Goiânia 5
Haiphong 5
Kingston 5
Queens 5
Quito 5
Quảng Ninh 5
Sassari 5
Shanghai 5
Tampa 5
Baghdad 4
Betim 4
Bologna 4
Calgary 4
Casablanca 4
Charleston 4
Cleveland 4
Totale 3.335
Salva come PNG Salva come JPEG
Nome #
Idiopathic pulmonary fibrosis (IPF) and lung cancer 178
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 128
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 91
Il CSCC: aspetti distintivi della patologia 87
Germline and somatic NGS-based analysis on BRCA-related tumors 86
Progetto Alternanza scuola lavoro 2016 - Liceo Scientifico G.Marconi di Sassari 84
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population 83
Multiple primary melanomas from same patients present discrepant somatic alterations in main candidate genes 80
Functionals interactions of the MAPK-ERK gene pathway in melanoma pathogenesis. 79
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 75
A Functional Mammalian Target of Rapamycin Complex 1 Signaling Is Indispensable for c-Myc-Driven Hepatocarcinogenesis 74
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 73
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 73
Liquid biopsy in clinical oncology 73
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma 73
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 71
Microsatellite instability in melanocytic skin lesions (benign nevi, dysplastic nevi, and primary melanomas along with their metastases) 70
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 69
nalysis of Fanconi anemia genes in colorectal cancer. 68
Genetic alterations in main candidate genes during melanoma progression. 68
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 68
Molecular landscape profile of melanoma 68
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 67
Genetic Instability Markers in Cancer 65
Epidemiology and Genetic Susceptibility of Breast and Ovarian Cancer in Sardinian Population 64
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 64
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 63
Role of argininosuccinate synthetase (ASS) expression in response to arginine deiminase (ADI) in melanoma cell lines 62
Pattern and distribution of BRAF/NRAS and P16CDKN2A mutations among primary an secondary lesions in melanoma patients [abstract]. 60
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 58
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 56
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 55
Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia 55
Different pathogenetic mechanisms are underlying molecular alterations in fanconi and mismatch DNA repair genes among patients with colorectal carcinoma 54
Ngs-based analysis of atypical deep penetrating nevi 54
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 54
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 54
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21 53
Mammary-like adenocarcinoma of the vulva: a rare case report with next generation sequencing 53
Genetic alterations at chromosome 9p21 and melanoma progression. 51
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 51
Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma 50
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 50
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 48
Vitamin D status and risk for malignant cutaneous melanoma: recent advances 47
Overexpression of h-prune in breast cancer is correlated with advanced disease status 44
Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer 44
Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases 44
Evaluation of genetic heterogeneity in paired lymph node metastases from melanoma patients using next-generation sequencing (NGS) approaches 44
Immunoreactivity for Ca 125 and INI 1 loss of expression are useful markers in the diagnosis of vulvar proximal-type epithelioid sarcomas: Report of two cases 43
Complete and Durable Response to Combined Chemo/Radiation Therapy in EGFR Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases 43
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 42
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy 42
Comparison of multiple tumor lesions from the same melanoma patients using next-generation sequencing (NGS) approaches 41
Identification of candidate transcripts at chromosomes 10q25-q26 and 9p21 in endometrial cancer (EC) and malignant melanoma (MM). 41
Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells. 40
Female Adnexal Tumors of probable Wolffian Origin (FATWO): a case series with next-generation sequencing mutation analysis 40
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 38
Analyses of key-regulator genes in melanoma susceptibility and pathogenesis among patients from south Italy. 37
Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. 37
Multiple molecular pathways in melanomagenesis: Characterization of therapeutic targets 37
Molecular analysis of Fanconi anemia (FA) and mismatch repair (MMR) genes in patients with colorectal carcinoma 37
A novel candidate gene in human endometrial cancer at chromosome 10q26 37
Long non-coding RNA CASC2 in human cancer 37
Identification of predictive factors for the occurrence of predisposing MLH1 and MSH2 germline mutations among Sardinian patients with colorectal carcinoma 36
Analysis of the MAPK-ERK gene Pathway in primary and metastatic melanoma cell lines 36
NEMO-binding domain peptide inhibits proliferation of human melanoma cells. 36
Genetic alterations in main candidate genes during melanoma progression 36
Molecular alterations at chromosome 9p21 in melanocytic nevi and melanoma. 35
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 34
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 34
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma 34
Molecular classification for the management of melanoma patients. 33
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas 33
Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer. 33
Vitamin D status and risk for malignant cutaneous melanoma: recent advances 33
Liquid biopsy in prostate cancer: A multidisciplinary expert consensus statement 33
NEMO-binding domain peptide inhibits proliferation of human melanoma cells. 32
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy 32
Tumour microenvironment heterogeneity in primary and metastatic paired melanoma samples and its correlation with genetic features and prognosis 31
Sequential accumulation of molecular alterations at the chromosome 9p21 during development and progression of melanoma. 31
Epidemiological and genetic factors underlying melanoma development in Italy 31
Prevalence of BRAF and NRAS mutations in primary tumours and different types of metastasis among melanoma patients 31
BRAF-NRAS mutation analysis among primary tumors and metastases at different sites from patients with melanoma 31
Mutation analysis of candidate genes in familial cases with malignant melanoma: identification of an additional susceptibility region at chromosome 9p21 31
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 31
Fanconi genes may contribute to melanoma pathogenesis. 30
Epidemiological features and prognostic parameters of multiple primary melanomas in CDKN2A-mutations patients 30
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 30
Estratto fenolico di bacche di mirto comune e composizione farmaceutica orale contenente il suddetto estratto in combinazione con un complesso di vanadio 30
Discrepant alterations in main candidate genes among multiple primary melanomas 30
Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. 30
How to treat BRAF mutant metastatic melanoma? 30
Fanconi genes are altered in subsets of patients with sporadic colorectal carcinoma. 29
BRAF, NRAS and p16CDKN2A, mutations among primary and secondary melanomas from same patients 29
Expression of arginino-succinate synthetase (ASS) and response to arginine deiminase (ADI) treatment in a series of melanoma cell lines. AACR-NCI-EORTC 28
Germline mutations in candidate genes among patients with cutaneous melanoma from Sardinia. 28
Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group 28
Role of the Fanconi gene pathway into the pathogenesis of melanoma. 28
The EGF 61A>G polymorphism has no role in nevi formation and melanoma pathogenesis within italian population 28
Totale 5.010
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.140
article - articoli 16.121
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 864
Totale 38.125
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202421 0 0 0 0 0 0 0 0 4 0 13 4
2024/20251.829 17 8 109 71 310 83 37 102 68 123 465 436
2025/20263.446 153 264 303 397 522 139 550 274 236 241 173 194
2026/2027827 224 188 415 0 0 0 0 0 0 0 0 0
Totale 6.123